Navigation Links
Meso Foundation Participates in Prestigious Conference on Lung Cancer

Washington, DC (PRWEB) October 26, 2013

On October 27 – 30, Mary Hesdorffer, Nurse Practitioner and executive director of the Mesothelioma Applied Research Foundation (Meso Foundation), and Melinda Kotzian, the chief executive officer of the Meso Foundation, are scheduled to attend and participate in the 15th World Conference on Lung Cancer in Sydney, Australia, organized by the International Association for the Study of Lung Cancer (IASLC).

They will be representing the Mesothelioma Applied Research Foundation and will be raising awareness of mesothelioma amidst over 7,000 delegates from over 100 countries.

In her capacity as an expert in mesothelioma treatment and care, Ms. Hesdorffer is scheduled to speak at several sessions, including one on the use of social media networks to communicate with and provide support to mesothelioma patients. Ms. Hesdorffer is a pioneer in this area. As a speaker, Ms. Hesdorffer’s travel and lodging costs are entirely covered by IASLC.

Ms. Kotzian’s travel costs are also covered through a grant by IASLC for which she applied earlier this year. She was one of five grant recipients from nonprofit organizations from all over the world awarded travel grants to enable them to attend this event.

"I am very grateful to IASLC for this grant," said Ms. Kotzian. "Being able to attend this important conference will allow me to represent the Foundation at a global level, thus helping advance the organization's mission of developing effective treatments and, ultimately, curing mesothelioma," she added.

The Meso Foundation will also be hosting a booth with information about mesothelioma and programs and services provided by the Foundation.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. Approximately 3,500 Americans are diagnosed with mesothelioma every year and an estimated one-third were exposed in Navy ships or shipyards.

The Meso Foundation is the only 501(c)3 non-profit organization dedicated to eradicating mesothelioma and easing the suffering caused by it. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish more effective treatments for mesothelioma and, ultimately, a cure for this rare, but extremely aggressive, cancer. To date, the Foundation has awarded over $8.2 million to research.

More information is available at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Junqian (Gordon) Xu, PhD, Awarded $150,000 Grant from Radiological Society of North American Research and Education Foundation
2. According to the United Health Foundation, The Burden of Diabetes in Missouri is on the Rise, Affecting Over Ten Percent of Residents
3. Sensory Processing Disorder Foundation Celebrates National Sensory Awareness Month
4. Miracle-Ear Foundation Gives the Gift of Sound to First Adult Recipient
5. Gates Foundation and Mayo Clinic Experts to Address Vaccine Research in the 21st Century
6. Kevin Nealon to Host Second Annual Celebrity Golf Classic to Benefit Melanoma Research Foundation November 18th
7. Delray Recovery Center Presenting the Brandi’s Wish Foundation’s 3rd Annual Weekend Tennis Event
8. Colleen’s Dream Foundation Gifts $10,000 to The University of Texas MD Anderson Cancer Center to Support Ovarian Cancer Research
9. International Essential Tremor Foundation to Facilitate Educational Seminar in Suffern, N.Y.
10. National Science Foundation BRAIN Workshop Report e-Published on IEEE Transactions on Biomedical Engineering
11. Migraine Research Foundation Hits Hole-in-One With Golf Outing and Benefit
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: